Quick Comparison

EGF (Epidermal Growth Factor)Retinyl Palmitate
Typical ConcentrationConcentrations vary by product (typically measured in ppm or sh-oligopeptide-1 percentage). Applied once or twice daily. Best used after procedures or on aging skin. Apply before oils/occlusives. Store in refrigerator for stability.Concentrations: 0.1-1%. Can often be used daily without irritation. Found in many moisturizers and eye creams. Minimal retinization period compared to stronger retinoids.
ApplicationTopical (serum, cream, ampoule). Apply to clean skin. Temperature-sensitive — some products require refrigeration.Topical (cream, lotion, eye cream). Very stable in formulation. Can be used morning or night.
Research Papers10 papers10 papers
Categories

Mechanism of Action

EGF (Epidermal Growth Factor)

EGF binds EGFR/ErbB1 on keratinocytes and fibroblasts, triggering dimerization and autophosphorylation. Activates MAPK/ERK (Ras-Raf-MEK-ERK) and PI3K/AKT pathways, promoting proliferation, migration (actin reorganization, focal adhesion turnover), and differentiation. Upregulates cyclin D1, inhibits p27. Stimulates fibroblast collagen types I/III and hyaluronic acid via HAS2. In wound healing, accelerates re-epithelialization via keratinocyte migration and reduces scarring via TGF-beta modulation. For anti-aging, promotes cellular renewal and extracellular matrix production. Theoretical cancer concern from EGFR's growth role — topical EGF has not been shown to penetrate to basal layer or systemic circulation significantly.

Retinyl Palmitate

Retinyl palmitate is cleaved by cutaneous esterases (including retinyl ester hydrolase) to release retinol, which then undergoes oxidation by retinol dehydrogenase to retinaldehyde, followed by RALDH conversion to retinoic acid. The three-step enzymatic cascade means very little active retinoic acid reaches nuclear RAR receptors at any given time, explaining the low potency and minimal retinization. The palmitate ester bond provides exceptional stability — resistant to UV-induced isomerization and oxidative degradation that affects retinol. This slow-release profile makes it suitable for sensitive skin and daytime use. The limited retinoic acid flux still provides mild stimulation of collagen type I synthesis and epidermal turnover, though clinical effects are subtle compared to stronger retinoids.

Risks & Safety

EGF (Epidermal Growth Factor)

Common

Very well-tolerated.

Serious

Theoretical concern about promoting growth of pre-existing skin cancers (unproven but debated).

Rare

Mild irritation.

Retinyl Palmitate

Common

Very mild — occasional dryness.

Serious

Theoretical pregnancy concern (retinoid class), though risk is very low.

Rare

Mild irritation in very sensitive skin.

Full Profiles